EMD Serono Announces Healthcare Leadership Changes for Global Commercial Strategy and North America
Not intended for media outside the U.S. or Canada
EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that Miguel Fernández Alcalde has been appointed Head of Global Commercial Strategy. Monia Vial is appointed President of EMD Serono, Head of North America, succeeding Fernández Alcalde.
"Miguel has consistently demonstrated the vision, agility, and commitment to patients that this role demands, across geographies, business functions, and every level of leadership. He is exceptionally well positioned to shape our global commercial strategy for the future," said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck KGaA, Darmstadt, Germany. “Looking ahead, Monia brings to our company deep leadership experience in the United States, along with invaluable international perspective and cultural fluency. Over the last eight years, she has built a rare disease franchise from the ground up, delivering outstanding results across multiple brands, indications, and product launches.”
Fernández Alcalde succeeds Andrew Paterson, who has made the decision to retire after 31 years with Merck KGaA, Darmstadt, Germany.
